The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase)
Open accessAbstract
NAD(P)H:quinone oxidoreductase (NQO1, EC 1.6.99.2) is an obligate two-electron reductase that can either bioactivate or detoxify quinones and has been proposed to play an important role in chemoprevention. We have previously characterized a homozygous point mutation in the BE human colon carcinoma cell line that leads to a loss of NQO1 activity. Sequence analysis showed that this mutation was at position 609 of the NQO1 cDNA, conferring a proline to serine substitution at position 187 of the NQO1 enzyme. Using polymerase chain reaction (PCR) analysis, we have found that the H596 human non-small-cell lung cancer (NSCLC) cell line has elevated NQO1 mRNA, but no detectable enzyme activity. Sequencing of the coding region of NQO1 from the H596 cells showed the presence of the identical homozygous point mutation present in the BE cell line. Expression and purification of recombinant wild-type and mutant protein from E. coli showed that mutant protein could be detected using immunoblot analysis and had 2% of the enzymatic activity of the wild-type protein. PCR and Northern blot analysis showed moderate to low levels of expression of the correctly sized transcript in the mutant cells. Immunoblot analysis also revealed that recombinant mutant protein was immunoreactive; however, the mutant protein was not detected in the cytosol of either BE or H596 cells, suggesting that the mutant proteins were either not translated or were rapidly degraded. The absence of any detectable, active protein, therefore, appears to be responsible for the lack of NQO1 activity in cells homozygous for the mutation. A polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis for the mutation at position 609 conducted on 90 human lung tissue samples (45 matched sets of tumour and uninvolved tissue) revealed a 7% incidence of individuals homozygous for the mutation, and 42% heterozygous for the mutation. These data suggest that the mutation at position 609 represents a polymorphism in an important xenobiotic metabolizing enzyme, which has implications for cancer therapy, chemoprevention and chemoprotection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Zhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682
(2008) · Encyclopedia of Genetics, Genomics, Proteomics and Informatics · doi:10.1007/978-1-4020-6754-9_2795 · Cited by 1,243
Benson, A. M., Hunkeler, M. J., & Talalay, P. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5216 · Cited by 746
Fujiki, H. (1986) · PubMed · Cited by 527
Rapid detection of inducers of enzymes that protect against carcinogens.
Prochaska, H. J., Santamaria, A. B., & Talalay, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2394 · Cited by 392
Li, R., Bianchet, M. A., Talalay, P., & Amzel, L. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8846 · Cited by 331
Traver, R. D., Horikoshi, T., Danenberg, K. D., Stadlbauer, T. H. W., Danenberg, P. V., Ross, D., & Gibson, N. W. (1992) · PubMed · Cited by 313
Self-citationA rapid micromethod for determination of FMN and FAD in mixtures
Faeder, E. J., & Siegel, L. M. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90442-9 · Cited by 288
Schlager, J. J., & Powis, G. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450304 · Cited by 262
Siegel, D. M., Nw, G., Preusch, P. C., & Ross, D. (1990) · PubMed · Cited by 222
Self-citationHuman NAD(P)H:quinone oxidoreductase (NQO1) gene structure and induction by dioxin
Jaiswal, A. K. (1991) · Biochemistry · doi:10.1021/bi00108a007 · Cited by 215
DT-diaphorase in activation and detoxification of quinones: Bioreductive activation of mitomycin C
Ross, D., Siegel, D., Beall, H., Prakash, A. S., Mulcahy, R. T., & Gibson, N. W. (1993) · Cancer and Metastasis Reviews · doi:10.1007/bf00689803 · Cited by 202
Self-citationPharmacogenetic Phenotyping and Genotyping: Present Status and Future Potential
Gonzalez, F. J., & Idle, J. R. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199426010-00005 · Cited by 187
Wattenberg, L. W. (1996) · Preventive Medicine · doi:10.1006/pmed.1996.0015 · Cited by 177
Jaiswal, A. K., McBride, O. W., Adesnik, M., & Nebert, D. W. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68280-8 · Cited by 170
Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones
Egner, P. A., Kensler, T. W., Prestera, T., Talalay, P., Libby, A. H., Joyner, H. H., & Curphey, T. J. (1994) · Carcinogenesis · doi:10.1093/carcin/15.2.177 · Cited by 142
Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
Beall, H. D., Mulcahy, R. T., Siegel, D. M., Traver, R. D., Gibson, N. W., & Ross, D. (1994) · PubMed · Cited by 102
Self-citationHuman FAD-dependent NAD(P)H diaphorase
Edwards, Y. H., Potter, J., & Hopkinson, D. A. (1980) · Biochemical Journal · doi:10.1042/bj1870429 · Cited by 81
Gibson, N. W., Hartley, J. A., Butler, J., Siegel, D., & Ross, D. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08965-5 · Cited by 75
Self-citationEnzymology of the reductive bioactivation of SR 4233
Walton, M. I., & Workman, P. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90119-6 · Cited by 69
Ross, D., Traver, R. D., Siegel, D. M., KUEHL, B. L., Misra, V., & Rauth, A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.477 · Cited by 68
Self-citationMa, Q., Cui, K., Xiao, F., Lu, A., & Yang, C. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41669-9 · Cited by 57
Detection of a Point Mutation in NQ01 (DT-diaphorase) in a Patient With Colon Cancer
Kolesar, J., Kuhn, J. G., & Burris, H. A. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.13.1022-a · Cited by 25
Cited by
Ross, D., Kepa, J. K., Winski, S. L., Beall, H. D., Anwar, A., & Siegel, D. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00199-x · Cited by 621
Self-citationThe diverse functionality of NQO1 and its roles in redox control
Ross, D., & Siegel, D. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101950 · Cited by 499
Self-citationThe Nrf2 System as a Potential Target for the Development of Indirect Antioxidants
Jung, K.-A., & Kwak, M.-K. (2010) · Molecules · doi:10.3390/molecules15107266 · Cited by 474
NAD(P)H:Quinone Oxidoreductase 1: Role as a Superoxide Scavenger
Siegel, D., Gustafson, D. L., Dehn, D. L., Han, J. Y., Boonchoong, P., Berliner, L. J., & Ross, D. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1238 · Cited by 455
Self-citationNioi, P., & Hayes, J. D. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.05.023 · Cited by 362
Metadata
- Authors
- Traver, R., Siegel, D., Beall, H., Phillips, R., Gibson, N., Franklin, W., & Ross, D.
- Venue
- British Journal of Cancer
- Published
- 1997-01
- Volume
- 75
- Issue
- 1
- Pages
- 69-75
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1990780198
- Cited by
- 303
- References
- 25
- FWCI
- 22.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.